Zhuzhou Qianjin Pharmaceutical Co., Ltd.

Zhuzhou Qianjin Pharmaceutical Co., Ltd. has experienced a recent evaluation adjustment, reflecting a shift in its stock valuation metrics. Key financial indicators include a P/E ratio of 19 and a price-to-book value of 1.78, while the company faces challenges in long-term growth and has underperformed the market.

Zhuzhou Qianjin Pharmaceutical Co., Ltd. saw a notable decline in its stock today, contrasting with the broader market's performance. Over the past week and month, the stock has experienced significant decreases, while year-to-date figures show it underperforming compared to the market. Financial metrics reveal slow growth in net sales and operating profit.